Caris Life Sciences

Recent news

• Company notice
  UOB Kay Hian: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED
  SGX · 2026/9/8
• Company notice
  UOB Kay Hian: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED
  SGX · 2026/9/3
• Rating change
  I-MAB Buy Rating: Strategic Pivot to U.S. Market and Promising Pipeline
  TipRanks · 2024/2/12
• Trump: The U.S.-Iran war has reached a critical juncture, and I am facing a major decision.
  cls.cn · 2026/9/18
• Fed's Barr Says Resilience Of U.S. Economy Is Striking; I Don't Have Recession In My Base Case; Momentum Seems To Be Building In The Economy
  Benzinga · 2026/9/30
• Company notice
  UOB Kay Hian: Disclosure of Interest/ Changes in Interest of Substantial Shareholder(s)/ Unitholder(s)-NOTIFICATION FOR SUBSTANTIAL SHAREHOLDER - U.I.P. HOLDINGS LIMITED
  SGX · 2026/9/14
• Company notice
  FLOWING CLOUD: REVISED EXPECTED TIMETABLE IN RELATION TO(I) PROPOSED INCREASE IN AUTHORISED SHARE CAPITAL;(II) PROPOSED CHANGE IN BOARD LOT SIZE;AND(III) PROPOSED RIGHTS ISSUE ON THE BASIS OFFOUR (4) RIGHTS SHARES FOR EVERY ONE (1) SHAREHELD ON THE RECORD DATE ON A NON-U
  HKEX · 2026/10/5
• U.S. Stock Market Moves | Ferrovial rises 3.6% in pre-market trading after securing $9.2 billion public-private partnership for Tennessee I-24 Express Lanes
  Gelonghui Finance · 2026/8/20
• U.S. Treasury Secretary Bessent: Trump and I have full confidence in Federal Reserve Chair Warsh
  Breakings · 2026/9/21
• U.S. stocks are clearly in a state of "euphoria"! Howard Marks: This is one of the most challenging situations I have encountered in my investment career, but uncertainty about the future is not a reason to refrain from investing...
  The Intelligent Investor · 2026/9/7
• Company notice
  ASCLETIS-B: VOLUNTARY ANNOUNCEMENT - ASCLETIS ANNOUNCES INITIATION OF PHASE I STUDY IN U.S.FOR ORAL AMYLIN RECEPTOR PEPTIDE AGONIST ASC36 FOR THETREATMENT OF OBESITY
  HKEX · 2026/9/8

Headlines are aggregated automatically and are not independently verified or edited by our team.